Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress

Author: Ito Koichi   Scott Stacy   Cutler Samuel   Dong Lan-Feng   Neuzil Jiri   Blanchard Helen   Ralph Stephen  

Publisher: Springer Publishing Company

ISSN: 0969-6970

Source: Angiogenesis, Vol.14, Iss.3, 2011-09, pp. : 293-307

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content